Whitehawk Therapeutics, Inc. (NASDAQ:WHWK – Get Free Report) CEO David James Lennon sold 26,858 shares of the firm’s stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $3.48, for a total value of $93,465.84. Following the completion of the sale, the chief executive officer directly owned 793,549 […]

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) insider Barry Ticho sold 6,686 shares of the company’s stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $31.34, for a total value of $209,539.24. Following the completion of the sale, the insider owned 40,798 shares of the company’s […]